Skip to content
Screener

GRAIL, Inc. GRAL Business Segments — Total Costs & Expenses

Similar metrics at other companies

Archer Aviation logo
ACHRReportable Segment — Total Costs & Expenses
$256.2M+77.9%
BridgeBio Pharma logo
BBIOReportable Segment — Total Costs & Expenses
$300.47M+36.0%
AIR
AIRSReportable Segment — Total Costs & Expenses
$41.19M+0.6%
Twist Bioscience Corporation logo
TWSTReportable Segment — Total Costs & Expenses
$156.58M+16.5%
Lumen Technologies logo
LUMNReportable Segment — Total Costs & Expenses
$2.3B-25.3%
Pacira BioSciences, Inc. logo
PCRXReportable Segment — Total Costs & Expenses
$170.47M+2.1%

Other financials

Income statement

See full
Revenue$44.7M+25.7%
Operating income-$173.8M-9.4%
Net income-$110.2M+3.3%
EPS (diluted)-$2.56+19.5%

Balance sheet

See full
Cash & equivalents$62.6M-52.1%
Total debt$91.3M+46.9%
Total equity$2.5B+9.9%
Total assets$2.8B+5.2%

Cash flow

See full
Operating cash flow-$80.7M-4.9%
CapEx$432.0K+17.1%
Free cash flow-$81.2M-4.9%

Valuation

See full
Market cap$2.72B+129%
Enterprise value$2.75B+145%
P/S16.5×+7.6×

Profitability

See full
Operating margin-338.4%-74.4pp
Net margin-236.9%-52.1pp
FCF margin-179.2%-46.7pp

Returns & leverage

See full
Return on equity-16.1%-1.3pp
Debt / equity0.0×
Current ratio10.9×+1.7×

Where this comes from

Reported directly by GRAIL, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: GRAIL, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054307
Line itemThree Months Ended / June 30,2026Three Months Ended / June 30,2025Six Months Ended / June 30,2026Six Months Ended / June 30,2025
Sales and marketing37,65728,53968,32563,518
General and administrative50,70837,91493,47782,988
Intangible and other assets impairment25,42328,00025,42328,000
Total costs and operating expenses218,470194,398395,020379,842
Loss from operations(173,783)(158,854)(309,548)(312,461)
Other income:
Interest income7,2306,80915,21614,588
Other income (expense), net(155)(811)101(1,395)

Item 1. Financial Statements

FAQ

What is GRAIL, Inc.'s business segments — total costs & expenses?
GRAIL, Inc. (GRAL) reported business segments — total costs & expenses of $218.47M in Q2 2026.
How has GRAIL, Inc.'s business segments — total costs & expenses changed year-over-year?
GRAIL, Inc.'s business segments — total costs & expenses increased by 12.4% year-over-year, from $194.4M to $218.47M.
What is the long-term trend for GRAIL, Inc.'s business segments — total costs & expenses?
Over 3 years (2022 to 2025), GRAIL, Inc.'s business segments — total costs & expenses has grown at a -49.5% compound annual growth rate (CAGR), from $5.5B to $709.34M.
What does business segments — total costs & expenses mean?
This represents the total aggregate operating costs and expenses incurred by the specific business segment during the reporting period. It encompasses all direct and indirect expenditures, including research and development, clinical trial costs, and administrative overhead required to support the segment's operations. Monitoring this metric helps assess the operational scale and cost structure efficiency of the business unit.

Ask your AI about GRAIL, Inc.'s business segments — total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude